A State Authority Perspective on Medicaid Reimbursement for Cell & Gene Therapies
Time: 9:30 am
day: Conference Day Two
Details:
- Sharing experiences on negotiating payment terms with manufacturers
- The new Medicaid Drug Rebate Program Final Rule & CMMI Access Models: how are these impacting CGT reimbursement at the state-level in 2025?
- Discussing CGT patient data evidence generation efforts
Speakers:
